These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28766409)

  • 1. Phase 1 healthy volunteer willingness to participate and enrollment preferences.
    Chen SC; Sinaii N; Bedarida G; Gregorio MA; Emanuel E; Grady C
    Clin Trials; 2017 Oct; 14(5):537-546. PubMed ID: 28766409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research.
    Grady C; Bedarida G; Sinaii N; Gregorio MA; Emanuel EJ
    Clin Trials; 2017 Oct; 14(5):526-536. PubMed ID: 28783972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
    Fisher JA; McManus L; Cottingham MD; Kalbaugh JM; Wood MM; Monahan T; Walker RL
    PLoS Med; 2018 Nov; 15(11):e1002698. PubMed ID: 30457992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research.
    Wang Z; Chen G; Liu X; Liu C; Song Q; Wang J
    Eur J Clin Pharmacol; 2021 Apr; 77(4):557-568. PubMed ID: 33188452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Picking and Choosing Among Phase I Trials : A Qualitative Examination of How Healthy Volunteers Understand Study Risks.
    Fisher JA; Monahan T; Walker RL
    J Bioeth Inq; 2019 Dec; 16(4):535-549. PubMed ID: 31713712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why healthy subjects volunteer for phase I studies and how they perceive their participation?
    Almeida L; Azevedo B; Nunes T; Vaz-da-Silva M; Soares-da-Silva P
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1085-94. PubMed ID: 17891536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
    Fisher JA; McManus L; Kalbaugh JM; Walker RL
    Clin Trials; 2021 Aug; 18(4):477-487. PubMed ID: 33938244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials.
    McManus L; Fisher JA
    AJOB Empir Bioeth; 2018; 9(2):82-90. PubMed ID: 29693508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehension and recall from the informed consent process by phase I healthy volunteers before dose administration.
    Tadros R; Caughey GE; Johns S; Shakib S
    Clin Trials; 2019 Jun; 16(3):283-289. PubMed ID: 30818994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthy participants in phase I clinical trials: the quality of their decision to take part.
    Rabin C; Tabak N
    J Clin Nurs; 2006 Aug; 15(8):971-9. PubMed ID: 16879541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How important is 'accuracy' of surrogate decision-making for research participation?
    Kim SY; Kim HM; Ryan KA; Appelbaum PS; Knopman DS; Damschroder L; De Vries R
    PLoS One; 2013; 8(1):e54790. PubMed ID: 23382969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding preferences regarding consent for pragmatic trials in acute care.
    Dickert NW; Wendler D; Devireddy CM; Goldkind SF; Ko YA; Speight CD; Kim SY
    Clin Trials; 2018 Dec; 15(6):567-578. PubMed ID: 30280582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea.
    Seo JH; Kim OJ; Yoo SH; Choi EK; Park JE
    J Empir Res Hum Res Ethics; 2022; 17(1-2):193-212. PubMed ID: 34414819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gender on the decision to participate in a clinical trial: a cross-sectional study.
    Lobato L; Bethony JM; Pereira FB; Grahek SL; Diemert D; Gazzinelli MF
    BMC Public Health; 2014 Nov; 14():1156. PubMed ID: 25377601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using "clinical trial diaries" to track patterns of participation for serial healthy volunteers in U.S. phase I studies.
    Edelblute HB; Fisher JA
    J Empir Res Hum Res Ethics; 2015 Feb; 10(1):65-75. PubMed ID: 25742668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining reasonable patient standard and preference for shared decision making among patients undergoing anaesthesia in Singapore.
    Yek JL; Lee AK; Tan JA; Lin GY; Thamotharampillai T; Abdullah HR
    BMC Med Ethics; 2017 Feb; 18(1):6. PubMed ID: 28148256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who is willing to participate in low-risk pragmatic clinical trials without consent?
    Dal-Ré R; Carcas AJ; Carné X
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1557-1563. PubMed ID: 28900674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial.
    Cattapan A; Browne K; Halperin DM; Di Castri A; Fullsack P; Graham J; Langley JM; Taylor BA; McNeil SA; Halperin SA
    Vaccine; 2019 Jan; 37(2):289-295. PubMed ID: 30528592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthy individuals' perspectives on clinical research protocols and influences on enrollment decisions.
    Roberts LW; Kim JP
    AJOB Empir Bioeth; 2017; 8(2):89-98. PubMed ID: 28949845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.
    Fisher JA; McManus L; Wood MM; Cottingham MD; Kalbaugh JM; Monahan T; Walker RL
    J Empir Res Hum Res Ethics; 2018 Dec; 13(5):494-510. PubMed ID: 30296882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.